Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

MLA

Stocco, Gabriele, et al. “Thiopurine Metabolites Variations during Co-Treatment with Aminosalicylates for Inflammatory Bowel Disease: Effect of N-Acetyl Transferase Polymorphisms.” World Journal of Gastroenterology, vol. 21, no. 12, Mar. 2015, pp. 3571–78. EBSCOhost, https://doi.org/10.3748/wjg.v21.i12.3571.

APA

Stocco, G., Cuzzoni, E., De Iudicibus, S., Favretto, D., Malusà, N., Martelossi, S., Pozzi, E., Lionetti, P., Ventura, A., & Decorti, G. (2015). Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms. World Journal of Gastroenterology, 21(12), 3571–3578. https://doi.org/10.3748/wjg.v21.i12.3571

Chicago

Stocco, Gabriele, Eva Cuzzoni, Sara De Iudicibus, Diego Favretto, Noelia Malusà, Stefano Martelossi, Elena Pozzi, Paolo Lionetti, Alessandro Ventura, and Giuliana Decorti. 2015. “Thiopurine Metabolites Variations during Co-Treatment with Aminosalicylates for Inflammatory Bowel Disease: Effect of N-Acetyl Transferase Polymorphisms.” World Journal of Gastroenterology 21 (12): 3571–78. doi:10.3748/wjg.v21.i12.3571.